The impact of SARS-CoV-2 vaccination in Dravet syndrome: A UK survey.

ABSTRACT:

Background

The COVID-19 pandemic led to the urgent need for accelerated vaccine development. Approved vaccines have proved to be safe and well tolerated across millions of people in the general population. Dravet syndrome (DS) is a severe, early onset, developmental and epileptic encephalopathy. Vaccination is a precipitating factor for seizures. While there is no evidence that vaccine-precipitated seizures lead to adverse outcomes in people with DS, fear surrounding vaccination can remain for caregivers of people with DS, in some cases resulting in rejection of recommended vaccinations, leaving individuals more vulnerable to the relevant infections. A greater understanding of the safety profile of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in this

SUBMITTER: Clayton LM 

PROVIDER: S-EPMC8379095 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature